Tobacco and Public Health - TCSC Indonesia

BRIDGETTE E. GARRETT ET AL. 165
Risner, M. E. and Goldberg, S. R. (1983). A comparison of nicotine and cocaine self-administration
in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J Pharmacol
Exp Ther, 224, 319–26.
Robinson, T. E. and Berridge, K. C. (1993). The neural basis of drug craving: an incentive-sensitization
theory of addiction. Brain Res Rev, 18, 247–91.
Rose, J. E. and Corrigall, W. A. (1997). Nicotine self-administration in animals and humans: similarities
and differences. Psychopharmacol, 130, 28–40.
Rosecrans, J. A., Chance, W. T., and Schechter, M. D. (1976). The discriminative stimulus properties
of nicotine, d-amphetamine and morphine in dopamine depleted rats. Psychopharmacol
Communications, 2, 349–56.
Royal College of Physicians of London (2000). Nicotine addiction in Britain: a report of the Tobacco
Advisory Group of the Royal College of Physicians. London: Royal College of Physicians.
Schechter, M. D. and Rosecrans, J. A. (1972). Nicotine as a discriminative stimulus in rats depleted of
norepinephrine or 5-hydroxytryptamine. Psychopharmacologia, 24, 417–29.
Shoaib, M. and Stolerman, I. P. (1996). Brain sites mediating the discriminative stimulus effects of
nicotine in rats. Behav Brain Res, 78, 183–8.
Shaham, Y., Adamson, L. K., Grocki, S., and Corrigall, W. A. (1997). Reinstatement and spontaneous
recovery of nicotine seeking in rats. Psychopharmacol, 130, 396–403.
Shoaib, M., Schindler, C. W., and Goldberg, S. R. (1997). Nicotine self-administration in rats: strain
and nicotine pre-exposure effects on acquisition. Psychopharmacol, 129, 35–43.
Shoaib, M., Zubaran, C., and Stolerman, I. P. (2000). Antagonism of stimulus properties of nicotine
by dihydro-beta-erythroidine (DHbetaE) in rats. Psychopharmacol, 149, 140–6.
Shoaib, M., Gommans, J., Morley, A., Stolerman, I. P., Grailhe, R., and Changeux, J. P. (2002).
The role of the nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned
taste aversion. Neuropharmacol, 42, 530–9.
Stolerman, I. P., Fink, R., and Jarvic, M. E. (1973). Acute and chronic tolerance to nicotine measured
by activity in rats. Psychopharmacol, 30, 329–42.
Stolerman, I. P., Garcha, H. S., Pratt, J. A., and Kumar, R. (1984). Role of training dose in discrimination
of nicotine and related compounds by rats. Psychopharmacol, 84, 413–9.
Stolerman, I. P. and Jarvis, M. J. (1995). The scientific case that nicotine is addictive.
Psychopharmacol, 117, 2–10.
Stolerman, I. P., Chandler, C. J., Garcha, H. S., and Newton, J. S. (1997). Selective antagonism
of the behavioral effects of nicotine by dihydro-β-erythroidine in rats. Psychopharmacol, 129,
390–7.
Thompson, T. and Schuster, C. R. (1968). Behavioral Pharmacology, Englewood Cliffs (NJ)
Prentice-Hall.
US Department of Health and Human Services (1998). The health consequences of smoking: nicotine
addiction. A report of the Surgeon General. Washington (DC): US Government Printing Office.
US Food and Drug Administration (1996). 21 CFR Part 801, et al. Regulations restricting the sale and
distribution of cigarettes and smokeless tobacco to protect children and adolescents; final rule,
Federal Register, 61(168) Washington (DC): Government Printing Office, pp. 44396–5318.
Wise, R. A. and Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological
Rev, 94, 469–92.
World Health Organization (1992). The ICD-10 classification of mental and behavioural disorders:
clinical description and diagnostic guidelines. Geneva, Switzerland: World Health Organization.
World Health Organization, Scientific Advisory Committee on Tobacco Product Regulation (2003).
Recommendation on Tobacco Product Ingredients and Emissions.